Key facts
- HSBC is selling its Singapore life and health insurance business to Allianz for $2.1 billion.
- The deal is expected to be completed in the first half of 2027, pending regulatory approval.
- HSBC and Allianz will form a 15-year partnership for insurance product sales.
- The transaction is anticipated to yield a pre-tax gain of approximately £1.4 billion for HSBC.
- HSBC will receive an upfront payment of £150.1 million.
- The sale aligns with HSBC's strategy to simplify its operations and focus on core strengths.
HSBC has agreed to sell its life and health insurance business in Singapore to German insurance giant Allianz for $2.1 billion (£1.6 billion). The deal, which is expected to be finalized in the first half of 2027 pending regulatory approval, is part of HSBC's broader strategy to simplify its operations and focus on areas where it holds a competitive advantage.
Upon completion, HSBC and Allianz will enter into a 15-year partnership. Under this agreement, HSBC will continue to offer insurance products to its retail banking and wealth management clients in Singapore, with Allianz owning and underwriting these policies. The transaction is anticipated to generate a pre-tax gain of approximately £1.4 billion for HSBC, alongside an upfront payment of £150.1 million.
HSBC Chief Executive Georges Elhedery, who launched a significant restructuring plan in October 2024, has been actively streamlining the bank's operations. This sale follows a strategic review that identified it as the optimal outcome for the bank's simplification efforts. The move allows HSBC to concentrate on its core competencies while reaffirming its commitment to Singapore as a crucial market for future growth.
For Allianz, this deal represents a second opportunity to establish a significant presence in the Singapore market, following a previous $2.2 billion bid for Income Insurance that was thwarted in 2024. Allianz anticipates that this transaction will yield a double-digit return in the medium term.